Rothschild Investment LLC’s Olema Pharmaceuticals OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.5K Buy
280
+55
+24% +$737 ﹤0.01% 2474
2026
Q1
$3.35K Sell
225
-2
-0.9% -$45 ﹤0.01% 2269
2025
Q4
$5.67K Buy
227
+2
+0.9% +$36 ﹤0.01% 1822
2025
Q3
$2.2K Hold
225
﹤0.01% 2170
2025
Q2
$959 Buy
225
+205
+1,025% +$914 ﹤0.01% 2495
2025
Q1
$75 Sell
20
-10
-33% -$50 ﹤0.01% 2989
2024
Q4
$175 Sell
30
-20
-40% -$200 ﹤0.01% 2819
2024
Q3
$597 Buy
50
+40
+400% +$511 ﹤0.01% 2420
2024
Q2
$108 Buy
+10
New +$108 ﹤0.01% 2719

Other funds holding OLMA

Rothschild Investment LLC's OLMA Position: Q2 2026 in Review

Rothschild Investment LLC increased its Olema Pharmaceuticals (OLMA) stake by 24% in Q2 2026, buying an estimated $737 and bringing the position to 280 shares worth $3.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2474.

Rothschild Investment LLC first reported a position in OLMA in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.67K in Q4 2025. 45 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Rothschild Investment LLC held 280 shares of Olema Pharmaceuticals worth $3.5K as of Q2 2026.
  • Rothschild Investment LLC bought 55 Olema Pharmaceuticals shares in Q2 2026, an estimated $737.
  • Olema Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2474 holding.
  • Rothschild Investment LLC first reported a position in Olema Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Rothschild Investment LLC's Olema Pharmaceuticals position peaked at $5.67K in Q4 2025.
  • 45 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.